Araki Nobukazu, Hamasaki Masao, Egami Youhei, Hatae Tanenori
Department of Histology and Cell Biology, School of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan.
Cell Struct Funct. 2006;31(2):145-57. doi: 10.1247/csf.06029. Epub 2006 Dec 5.
In the process of receptor-mediated endocytosis, the fusion of endosomes in vitro is known to be inhibited by wortmannin or LY294002; inhibitors of phosphoinositide 3-kinase (PI3K), suggesting that the activity of PI3K is required for the fusion of early endosomes. In macropinocytosis, a process of bulk fluid-phase endocytosis, however, it remains unclear whether PI3K is required for the fusion of macropinosomes, since the macropinosome formation is inhibited by the PI3K inhibitors. In this study, we examined the effect of 3-methlyadenine (3-MA), which shows a distinct specificity to the PI3K classes from wortmannin and LY294002, on the macropinosome formation and fusion in EGF-stimulated A431 cells. Unlike wortmannin or LY294002, 3-MA did not inhibit the uptake of fluorescent dextran by macropinocytosis. However, the fusion of macropinosomes was inhibited by 3-MA. By imaging of live-cells expressing fluorescent protein-fused tandem FYVE domains, we found that PtdIns(3)P appeared on the macropinosomal membrane shortly after the closure of macropinocytic cups and remained on macropinosomes even at 60-min age. The production of PtdIns(3)P and the recruitment of EEA1 to macropinosomes were abolished by the 3-MA treatment. Therefore, it is likely that 3-MA impairs recruitment of EEA1 by inhibiting PtdIns(3)P production and resultantly blocks the fusion of macropinosomes. These results suggest that the local production of PtdIns(3)P implicates the fusion of macropinosomes via EEA1 as well as conventional early endosomes. However, the long association of PtdIns(3)P with macropinosomes may well be a cell-type specific feature of A431 cells.
在受体介导的内吞作用过程中,已知渥曼青霉素或LY294002(磷酸肌醇3激酶(PI3K)的抑制剂)会抑制体外内体的融合,这表明PI3K的活性是早期内体融合所必需的。然而,在巨胞饮作用(一种大量液相内吞作用过程)中,PI3K是否为巨胞饮体融合所必需仍不清楚,因为PI3K抑制剂会抑制巨胞饮体的形成。在本研究中,我们检测了3-甲基腺嘌呤(3-MA)对表皮生长因子(EGF)刺激的A431细胞中巨胞饮体形成和融合的影响,3-MA对PI3K类别的特异性与渥曼青霉素和LY294002不同。与渥曼青霉素或LY294002不同,3-MA不会抑制巨胞饮作用对荧光葡聚糖的摄取。然而,3-MA会抑制巨胞饮体的融合。通过对表达荧光蛋白融合串联FYVE结构域的活细胞进行成像,我们发现磷脂酰肌醇-3-磷酸(PtdIns(3)P)在巨胞饮杯闭合后不久出现在巨胞饮体膜上,甚至在60分钟时仍保留在巨胞饮体上。3-MA处理消除了PtdIns(3)P的产生以及早期内体抗原1(EEA1)向巨胞饮体的募集。因此,3-MA可能通过抑制PtdIns(3)P的产生损害EEA1的募集,并最终阻断巨胞饮体的融合。这些结果表明,PtdIns(3)P的局部产生通过EEA1参与了巨胞饮体以及传统早期内体的融合。然而,PtdIns(与巨胞饮体的长期关联很可能是A431细胞的一种细胞类型特异性特征。